FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387477005: Scopolamine hydrobromide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461655011 Scopolamine hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481568017 Scopolamine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492108011 Hyoscine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461655011 Scopolamine hydrobromide (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461655011 Scopolamine hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481568017 Scopolamine hydrobromide en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481568017 Scopolamine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492108011 Hyoscine hydrobromide en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1492108011 Hyoscine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
9421000188115 scopolamine bromhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
9421000188115 scopolamine bromhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hyoscine hydrobromide Is a Scopolamine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide Has disposition Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide Is modification of (attribute) Scopolamine (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide Is a Tropane alkaloid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide Is a Antispasmodic (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide Is a Muscarinic receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Hyoscine hydrobromide adverse reaction Causative agent (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide allergy Causative agent (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Scopolamine hydrobromide 0.25% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Scopolamine hydrobromide 0.4mg tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Scopolamine hydrobromide (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 0.25% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 0.125% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Ophthalmic hyoscine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing atropine sulfate and hyoscyamine sulfate and scopolamine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 1mg/72hours transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing papaveretum and scopolamine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 400micrograms/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 600micrograms/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide [central nervous system use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing scopolamine hydrobromide in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing scopolamine hydrobromide in transdermal dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide allergy Causative agent (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 2
Scopolamine hydrobromide trihydrate (substance) Is a False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide 150 microgram oral tablet Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Scopolamine hydrobromide 0.4mg tablet (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Scopolamine hydrobromide 0.4mg tablet (product) Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 2
Scopolamine hydrobromide trihydrate (substance) Is modification of (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)
Hyoscine hydrobromide 150 microgram oral tablet Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Scopolamine hydrobromide 0.4mg tablet (product) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule Has precise active ingredient False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection Has basis of strength substance (attribute) False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 2
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection Has precise active ingredient False Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 2
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely scopolamine (as scopolamine hydrobromide) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide adverse reaction Causative agent (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection Has basis of strength substance (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection Has precise active ingredient True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept) 1
Scopolamine hydrobromide anhydrous (substance) Is modification of (attribute) True Hyoscine hydrobromide Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start